Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filings

Filing date Description Form Filing Group View

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Copyright Morningstar